Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Very low-dose naloxone added to remifentanil infusion for pain in hip replacement surgery
IRCT20220111053694N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of naloxone in postoperative pain (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Pain outcomes. Started Feb 2021; status: completed.
02
Drugs
naloxone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220111053694N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220111053694N1.